3:1 Bonus Issue, 2150% Returns: Multibagger Smallcap Announces Record Date For Bonus; Shares Fall

Remedium Lifecare Limited has announced the issuance of bonus shares following robust fourth quarter results of FY24. This decision was finalized during the company's Board of Directors meeting on Monday, which also reviewed the unaudited financial results for the fourth quarter of fiscal year 2024 (Q4FY24). The board approved the issuance of bonus shares in a 3:1 ratio, marking the second such issuance in less than a year.

The bonus shares will be allocated in a 3:1 ratio, meaning shareholders will receive three fully paid equity shares of Re 1 each for every one equity share held as of the record date. This record date has been set for July 6, 2024. The bonus shares, once allotted, will rank equal in all respects with the existing equity shares, entitling holders to participate fully in any dividends and other corporate actions declared after their issuance.

Remedium Lifecare emphasized the importance of shareholder approval in this process. "Subject to the approval of the members in the Annual General Meeting and appropriate authorities, the Board has considered, approved, and recommended a Bonus Issue of 3 Equity Shares of Re. 1/- each fully paid up for every 1 Equity Share of Re. 1/- Each fully paid-up is held as of the Record date decided for this purpose," the company stated.

This forthcoming bonus share issuance follows a similar move less than a year ago. On July 28, 2023, Remedium Lifecare shares were traded 'ex-bonus', allowing for the fair distribution of bonus shares among eligible shareholders in a 9:5 ratio.

The company's ability to issue bonus shares twice within such a short period is indicative of its strong financial performance and robust growth trajectory. Remedium Lifecare has a history of strategic financial decisions aimed at enhancing shareholder value. Earlier in the year, the company also split the face value of its shares from Rs 5 to Re. 1, with the shares trading on an ex-split basis from February 23, 2024.

Despite the positive news, the shares of Remedium Lifecare were trading down by nearly 5% at Rs 73.65 per share on the Bombay Stock Exchange (BSE) as of 1:40 pm on the day of the announcement. However, the stock has gained just over 5% in the last one year. Over the last three years, Remedium Lifecare's stock has delivered multifold returns of more than 2,150%.

Remedium Lifecare Limited, formerly known as Roxy Exports Limited, was incorporated on February 19, 1988. The company operates in the pharmaceutical sector, aligning its business across two verticals: products and services. Its products business involves the trading and sale of Active Pharmaceutical Ingredients (APIs) and intermediates to both innovator and generic pharmaceutical companies in domestic and international markets, including regulated markets.

The services business complements the products segment, providing a comprehensive suite of pharmaceutical services that support the company's market presence and operational excellence. This dual focus enables Remedium Lifecare to maintain a strong market position and drive continuous growth.

The announcement of the bonus share issuance aligns with Remedium Lifecare's strategic vision of maintaining transparency and delivering value to its shareholders. The company's decision to issue bonus shares for the second time in less than a year reflects its strong financial footing and optimistic outlook for future growth.

As the record date of July 6, 2024, approaches, shareholders can look forward to the benefits of this bonus issuance. The move is expected to enhance shareholder wealth. The forthcoming Annual General Meeting will be a crucial event, where the shareholders' approval will mark another milestone in the company's journey of growth and success.